Clinical Trial Update: Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy

View source ↗

Summary

Completed clinical trial evaluating intramuscular injections of Botox (onabotulinumtoxinA) to assess changes in disease activity in pediatric spasticity due to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: AbbVie | Conditions: Spasticity | Status: COMPLETED